Rick Miller
Representative for Cantor Fitzgerald (asking on behalf of Kristen Kluska)
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q3 2024 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q3 2024 earnings conference call, held 2024-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alan Musso
Chief Financial Officer
Alex Sapir
Chief Executive Officer and President
Corinne Johnson
Analyst, Goldman Sachs
Julie Park
Representative (dialing in for Jill from Learing)
Edward Tintoff
Analyst, Piper Sandler
Matthew Beigler
Analyst, Oppenheimer
Dr. Ian Fraser
Senior Vice President of Development
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.069 -- 00:00:05.094 Good morning and welcome to Fulcrum Therapeutics third quarter 2024 00:00:05.094 -- 00:00:08.977 financial results and business update conference call. 00:00:08.977 -- 00:00:13.181 Currently all participants are in a listen only mode. 00:00:13.181 -- 00:00:18.286 This call is being webcast live and can be accessed on the investor section of 00:00:18.286 -- 00:00:22.668 Fulcrum's website at www.fulcrumtx.com 00:00:25.012 -- 00:00:27.287 and is being recorded. 00:00:27.287 -- 00:00:32.629 Please be reminded that remarks during this call may contain forward-looking statements 00:00:32.629 -- 00:00:38.390 within the meaning of the Private Securities Litigation Reform Act 00:00:38.390 -- 00:00:44.492 of 1995, may include statements about the company's future expectations and plans, 00:00:44.492 -- 00:00:49.074 clinical development timelines, and financial projections. 00:00:49.074 -- 00:00:54.144 While these forward-looking statements represent Fulcrum's views as of today, 00:00:54.144 -- 00:01:00.288 This should not be relied upon as representing the company's views in the future. 00:01:00.288 -- 00:01:05.471 Fulcrum may update these statements in the future, but is not taking on an 00:01:05.471 -- 00:01:10.714 obligation to do so. Please refer to Fulcrum's most recent filings 00:01:10.714 -- 00:01:16.058 with the Securities and Exchange Commission for discussions of certain risks 00:01:16.058 -- 00:01:20.600 and uncertainties associated with the company's business. 00:01:20.600 -- 00:01:25.978 Leading the call today will be Alex Sapir, CEO and President of Fulcrum. 00:01:25.978 -- 00:01:31.239 Joining Alex on the call are Alan Musso, Chief Financial Officer, Dr. 00:01:31.239 -- 00:01:36.621 Pat Horn, Chief Medical Officer, and Dr. Ian...